Successful treatment of sarcoidosis with cutaneous and pulmonary involvement with fumaric acid ester;Erfolgreiche therapie einer haut- und lungensarkoidose mit fumarsäureestern

Hautarzt

Volumn 55, Issue 6, 2004, Pages 553-557

  Gutzmer, R ^a   Kapp, A ^a   Werfel, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Angiotensin converting enzyme; Cutaneous sarcoidosis; Fumaric acid ester; Pulmonary sarcoidosis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; FUMADERM; FUMARIC ACID;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; HUMAN; LUNG SARCOIDOSIS; SARCOIDOSIS; SKIN DISEASE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

DERMATOLOGIC AGENTS; FEMALE; FUMARATES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; RECURRENCE; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; SKIN DISEASES; TREATMENT OUTCOME;

EID: 3042521447     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-004-0728-1     Document Type: Article

References (27)

1. Asadullah K, Schmid H, Friedrich M et al. (1997) Influence of monomethylfumarate on monocytic cytokine formation - explanation for adverse and therapeutic effects in psoriasis? Arch Dermatol Res 289:623-630
2. Bacharach-Buhles M, Pawlak FM, Matthes U et al. (1994) Fumaric acid esters (FAEs) suppress CD 15- and ODP 4-positive cells in psoriasis. Acta Derm Venereol Suppl 186:79-82
3. Bachelez H, Senet P, Cadranel J et al. (2001) The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137:69-73
4. Bergeron A, Bonay M, Kambouchner M et al. (1997) Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J Immunol 159:3034-3043
5. Brechtel B, Haas N, Henz BM, Kolde G (1996) Allopurinol: a therapeutic alternative for disseminated cutaneous sarcoidosis. Br J Dermatol 135:307-309
6. de Jong R, Bezemer AC, Zomerdijk TP et al. (1996) Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur J Immunol 26:2067-2074
7. Dümmler U, Rinke M, Sabel R, Gollnick H (1998) Sarkoidose mit kutaner Dissemination: Zwei Fälle unter Fumarsäuretherapie. Allergologie 8:387
8. English JC III, Patel PJ, Greer KE (2001) Sarcoidosis. J Am Acad Dermatol 44:725-743
9. Frizzell B, Stith M, Jenrette J (2002) Management of treatment-resistant cutaneous sarcoidosis with radiation. Am J Clin Oncol 25:573-575
10. Gambichler T, Kreuter A, Nowack U et al. (2003) Fumaric acid esters for treatment of cutaneous non-caseating granulomatous disorders. JDDG 1:Abstract P21.255
11. Graefe T, Konrad H, Barta U et al. (2001) Successful ultraviolet A1 treatment of cutaneous sarcoidosis. Br J Dermatol 145:354-355
12. Gutzmer R, Breuer K, Kiehl P et al. (2002) Successful therapy of annular elastolytic giant cell granuloma with fumaric acid esters. Dermatology 205:421-424
13. Hoch O, Muller S, Buttner G, Mensing H (2001) Thalidomid in der Behandlung der kutanen und systemischen Sarkoidose. Hautarzt 52:962-965
14. Hoxtermann S, Nuchel C, Altmeyer P (1998) Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis. Dermatology 196:223-230
15. Karrer S, Abels C, Wimmershoff MB et al. (2002) Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy. Arch Dermatol 138:581-584
16. Katoh N, Mihara H, Yasuno H (2002) Cutaneous sarcoidosis successfully treated with topical tacrolimus. Br J Dermatol 147:154-156
17. Kreuter A, Gambichler T, Altmeyer P, Brockmeyer NH (2003) Treatment of disseminated granuloma annulare with fumaric acid esters. BMC Dermatol 2:5
18. Liedtka JE (1996) Intralesional chloroquine for the treatment of cutaneous sarcoidosis. Int J Dermatol 35:682-683
19. Mahnke N, Medve-Koenigs K, Megahed M, Neumann NJ (2003) Medium-dose-UV-A1-Phototherapie. Erfolgreiche Behandlung einer kutanen Sarkoidose. Hautarzt 54:364-366
20. Moller DR, Forman JD, Liu MC et al. (1996) Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 156:4952-4960
21. Nowack U, Gambichler T, Hanefeld C et al. (2002) Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters. BMC Dermatol 2:15
22. Ockenfels HM, Schultewolter T, Ockenfels G et al. (1998) The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 139:390-395
23. Petres J, Kalkoff KW, Baron D et al. (1975) Der Einfluss von Fumarsäuremonoäthylester auf die Nukleinsäure- und Proteinsynthese PHA-stimulierter menschlicher Lymphocyten. Arch Dermatol Forsch 251:295-300
24. Pfau A, Stolz W, Karrer S et al. (1998) Allopurinol in der Behandlung der kutanen Sarkoidose. Hautarzt 49:216-218
25. Rousseau L, Beylot-Barry M, Doutre MS, Beylot C (1998) Cutaneous sarcoidosis successfully treated with low doses of thalidomide. Arch Dermatol 134:1045-1046
26. Schulze-Dirks A, Petzoldt D (2001) Granuloma anulare disseminatum - effolgreiche Therapie mit Fumarsäureester. Hautarzt 52:228-230
27. Sharma OP (2002) Pulmonary sarcoidosis: management. J Postgrad Med 48:135-14